J B Chemicals and Pharmaceuticals Ltd (JBCH)

NSE


	Symbol		Exchange		Currency
	JBCH		NSE		INR	Real-time
	JBCH		BSE		INR	Delayed

Currency in INR

1,833.50

-7.25(-0.39%)

Real-time Data13:53:11

Fair Value

Day's Range

1,809.00

1,865.35

52 wk Range

1,412.55

2,030.00

JBCH Income Statement

Featured here, the Income Statement (earnings report) for J B Chemicals and Pharmaceuticals Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

17,747.29

20,425.22

24,242.44

31,492.83

34,841.84

Total Revenues Growth

+8%

+15.09%

+18.69%

+29.91%

+10.63%

Cost Of Revenues

6,525.06

7,227.2

8,654.53

11,962.72

12,141.95

Gross Profit

11,222.23

13,198.02

15,587.91

19,530.11

22,699.89

Gross Profit Growth

+9.6%

+17.61%

+18.11%

+25.29%

+16.23%

Gross Profit Margin %

63.23%

64.62%

64.3%

62.01%

65.15%

Other Operating Expenses, Total

8,040.06

8,302.61

10,848.94

13,612.19

15,155.93

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.01%	+3.27%	+30.67%	+25.47%	+11.34%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,068.34	4,257.7	5,662.42	7,278.2	8,111.44
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,308.49	3,358.25	4,459.93	5,189.91	5,661.29

Operating Income

3,182.17

4,895.41

4,738.97

5,917.92

7,543.96

Operating Income Growth

+23.22%

+53.84%

-3.2%

+24.88%

+27.48%

EBIT Margin %

17.93%

23.97%

19.55%

18.79%

21.65%

Net Interest Expenses

11.84

-49.64

-31.46

-322.29

-392.26

Net Interest Expenses Growth

+605.55%

-519.27%

+36.63%

-924.56%

-21.71%

Interest Expense, Total

-29.17

-67.43

-40.85

-347.68

-436.52

Interest And Investment Income

41.01

17.79

9.39

25.39

44.26

Other Non Operating Expenses, Total

-2.93

93.22

-36.95

-113.66

38.28

EBT, Excl. Unusual Items

3,191.08

4,938.98

4,670.56

5,481.98

7,189.98

Gain (Loss) On Sale Of Assets

17.88

524.37

24.05

0.07

-2.32

Other Unusual Items, Total

-100

-

3.98

1.28

-

EBT, Incl. Unusual Items

3,488.92

5,968.85

5,049.02

5,552.33

7,515.09

EBT, Incl. Unusual Items Growth

+21.57%

+71.08%

-15.41%

+9.97%

+35.35%

EBT, Incl. Unusual Items Margin

19.66%

29.22%

20.83%

17.63%

21.57%

Income Tax Expense

765

1,483.62

1,188.63

1,452.27

1,988.81

Net Income to Company

2,723.92

4,485.23

3,860.39

4,100.05

5,526.28

Minority Interest

-3.45

-5.59

-6.82

-1.7

-

Net Income

2,720.47

4,479.64

3,853.57

4,098.36

5,526.28

Net Income Growth

+40.62%

+64.66%

-13.98%

+6.35%

+34.84%

Net Income Margin %

15.33%

21.93%

15.9%

13.01%

15.86%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

2,720.47

4,479.64

3,853.57

4,098.36

5,526.28

Basic EPS - Continuing Operations

17.1

28.98

24.93

26.5

35.66

Basic EPS - Continuing Operations Growth

+45.27%

+69.51%

-13.98%

+6.29%

+34.58%

Diluted EPS - Continuing Operations

17.1

28.98

24.91

26.17

34.85

Diluted EPS - Continuing Operations Growth

+45.27%

+69.5%

-14.04%

+5.06%

+33.17%

Basic Weighted Average Shares Outstanding

159.11

154.56

154.56

154.65

154.95

Diluted Weighted Average Shares Outstanding

159.11

154.56

154.71

156.62

158.59

Dividend Per Share

5.5

8.25

8.25

8.88

12.25

Dividend Per Share Growth

+120%

+50%

0%

+7.58%

+38.03%

EBITDA

3,757.3

5,498.25

5,384.41

7,037.85

8,896.31

EBITDA Growth

+19.99%

+46.34%

-2.07%

+30.71%

+26.41%

EBITDA Margin %

21.17%

26.92%

22.21%

22.35%

25.53%

EBIT